-Hindustan Times Rehman, who is in the embroidery business for more than 15 years, is one of thousands of artisans who are unable to get work as they did not register under GST, as is required now, and neither have textile firms that sent them cloth to work on. Ludhiana: Tucked away in the outskirts of the industrial city of Ludhiana, in New Kundan Puri area, embroiderer Abdul Rehman is sitting...

-The Tribune Punjab Govt looks other way, says no record of landless agri workers’ debt Chandigarh: While the Punjab Government dithers on providing debt relief to landless labourers, a new report suggests the number of suicides committed by landless agricultural labourers due to debt is much higher than those by farmers in the state. The “census report” commissioned by the Punjab Government on rural suicides takes into account incidences between 2010 and 2016...

-The Telegraph New Delhi: India's drug pricing rules allow companies to inflate the maximum retail prices of medicines, including life-saving drugs, costing patients thousands of additional rupees while offering slices of the profits to stockists, chemists, and hospitals. Quotations received by hospitals from drug companies' representatives offering discounts on maximum retail prices (MRPs) of medicines provide what some doctors and patients' rights advocates say is fresh evidence for excessive profiteering in India's...

-The Indian Express Punjab’s unique cattle breeding-cum-milk sale dairying model is under threat from gau rakshak activism and the Centre’s new animal trading rules. Randhawa and Gill are amongst Punjab’s many dairy farmers who have made the state into a major supplier of not just milk, but also milch animals. Gurdaspur (Punjab): “When there’s no land in our name, how would we now buy or sell cattle? Are they saying we...

-The Telegraph New Delhi: The government's price cap on coronary stents has not deterred the health-care industry from continuing to offer hospitals profit opportunities of tens of thousands of rupees on other kinds of stents, concerned doctors and health-care industry representatives said.     The National Pharmaceutical Pricing Authority (NPPA), the government's price regulator, had on February 15 imposed a cap of about Rs 30,000 on coronary stents. But hospitals can continue to...